| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
19,152 |
17,330 |
$1.65M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
25,864 |
23,646 |
$1.58M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
19,076 |
17,926 |
$742K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
7,878 |
7,545 |
$741K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
7,445 |
7,036 |
$701K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
6,161 |
5,562 |
$528K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
15,069 |
13,565 |
$233K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,187 |
2,023 |
$214K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,406 |
2,016 |
$181K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
4,795 |
4,199 |
$151K |
| 96127 |
|
6,681 |
6,139 |
$95K |
| 99177 |
|
5,467 |
5,163 |
$71K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,338 |
1,238 |
$51K |
| 90670 |
|
3,540 |
3,372 |
$51K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,626 |
2,504 |
$46K |
| 94760 |
|
13,237 |
11,399 |
$26K |
| 87634 |
|
350 |
321 |
$22K |
| 90461 |
|
9,761 |
9,198 |
$22K |
| 90686 |
|
7,634 |
7,208 |
$21K |
| 90716 |
|
845 |
822 |
$16K |
| 99381 |
|
147 |
142 |
$14K |
| 90651 |
|
236 |
221 |
$12K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
1,098 |
1,054 |
$10K |
| D0145 |
Oral evaluation for a patient under three years of age |
386 |
380 |
$10K |
| 90707 |
|
1,003 |
961 |
$10K |
| 90723 |
|
1,764 |
1,679 |
$9K |
| 90734 |
|
190 |
179 |
$5K |
| 99382 |
|
50 |
50 |
$5K |
| 90633 |
|
1,144 |
1,100 |
$5K |
| 99215 |
Prolong outpt/office vis |
46 |
41 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
91 |
90 |
$4K |
| 99383 |
|
37 |
37 |
$4K |
| 90677 |
|
142 |
127 |
$3K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
128 |
84 |
$3K |
| 90647 |
|
1,904 |
1,822 |
$3K |
| 36416 |
|
1,879 |
1,729 |
$2K |
| 0071A |
|
55 |
55 |
$2K |
| 90681 |
|
306 |
296 |
$2K |
| 90656 |
|
662 |
631 |
$2K |
| 90672 |
|
54 |
54 |
$1K |
| 0072A |
|
26 |
26 |
$1K |
| 83655 |
|
81 |
81 |
$971.19 |
| 90680 |
|
59 |
52 |
$791.83 |
| 81003 |
|
464 |
380 |
$718.35 |
| 90715 |
|
33 |
28 |
$695.08 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
37 |
37 |
$682.59 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
43 |
18 |
$433.88 |
| 80061 |
Lipid panel |
29 |
26 |
$408.65 |
| 90473 |
|
26 |
26 |
$209.75 |
| 90696 |
|
42 |
42 |
$191.19 |
| 85018 |
|
35 |
35 |
$108.28 |
| 90685 |
|
234 |
208 |
$89.89 |
| 96160 |
|
76 |
74 |
$81.89 |
| 90700 |
|
65 |
64 |
$35.55 |
| 91307 |
|
94 |
93 |
$0.00 |